✦ LIBER ✦

Pharmacokinetics of theophylline and enprofylline in patients requiring a high or low dose of theophylline

✍ Scribed by L. C. Laursen; N. Johannesson; B. Weeke

Publisher: Springer
Year: 1985
Tongue: English
Weight: 290 KB
Volume: 29
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00547379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacokinetics of theophylline and

The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease

✍ J. Kraan; J. H. G. Jonkman; G. H. Koëter; C. H. Gips; P. E. Jong; Th. W. Mark; I 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 516 KB

Pharmacokinetics of low-dose methotrexat

Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients

✍ Ronald A. Herman; Peter Veng-Pedersen; John Hoffman; Raechelle Koehnke; Daniel E 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Bioavailability and pharmacokinetics of

Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit I. Single dose study

✍ Y. Horai; T. Ishizaki; T. Sasaki; K. Chiba; T. Suganuma; H. Echizen; A. Ohnishi 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 787 KB

Slow release theophylline disposition an

Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: Influence of dose formulation and institutionalization

✍ Dr Patrick R. Montgomery; Fred Y. Aoki; Paul A. Mitenko; Michael Vanzieleghem; D 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 1 views

We studied the steady-state disposition of slow release theophylline tablets and granules in 12 institutionalized (I) and 12 community-dwelling (C) elderly patients with fixed chronic obstructive lung disease. Design was open label with random order crossover; each formulation was given 5 min before

Pharmacokinetics of an ultralong sustain

Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: Monitoring implications

✍ Juan A. Armijo; Blanca M. Sánchez; F. Galo Peralta; Mario González-Ruiz; Antonio 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

A Phase I and pharmacokinetic study of h

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

✍ Edward F. McClay; Mary-Eileen T. McClay; Jeffery A. Jones; Paul J. Winski; Rando 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

by 40 mg to the MTD in groups of 3 patients. DDP (80 mg/m 2 ) was begun on Day ogy/Oncology, Hollings Cancer Center, Medical 2 and repeated weekly for a total of 3 weeks. During Week 4, the patients were University of South Carolina, Charleston, South not treated with DDP but instead evaluated for r